Binosto 70 mg
Binosto 70 mg is a medicine authorised by Swissmedic under authorisation number 65165. The authorisation holder is EffRx Pharmaceuticals SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 12 April 2016 and the authorisation is valid without a time limit. ATC code M05BA04 places the medicine in the group Drugs for treatment of bone diseases.
| Authorisation number | 65165 |
|---|---|
| Name | Binosto 70 mg |
| Full name | Binosto 70 mg, Brausetabletten |
| Authorisation holder | EffRx Pharmaceuticals SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | M05BA04 |
| First authorisation | 12 April 2016 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Binosto 70 mg, Brausetabletten | B | 12 April 2016 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 4 | Tablette(n) | M05BA04 | 07.99.0. | B |
| 2 | 12 | Tablette(n) | M05BA04 | 07.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Binosto 70 mg authorised in Switzerland?
Yes. Binosto 70 mg is authorised by Swissmedic under authorisation number 65165, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Binosto 70 mg have?
Binosto 70 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Binosto 70 mg?
The authorisation holder is EffRx Pharmaceuticals SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.